|

CD7 CAR-T cells infusion Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Beijing GoBroad Hospital1

Indications

  • T-cell Lymphoma (PTCL and CTCL)1
  • T-cell Non-Hodgkin Lymphoma1
  • Cancer1

Other1 trial

CD7 CAR T-Cell Therapy for r/r T-cell Lymphomas
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.